Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases

• US 20060234947A1
• Filed: 06/21/2006
• Published: 10/19/2006
• Est. Priority Date: 01/31/2002
• Status: Active Grant

• Current Assignee: Tel Aviv University Future Technology Development L.P. (Tel Aviv University)
• Original Assignee: Tel Aviv University Future Technology Development L.P. (Tel Aviv University)
• Inventors: Gazit, Ehud
• Granted Patent: US 7,781,396 B2
• Time in Patent Office: Days
• US Class Current: 514/17.800
• CPC Class Codes: A61K 38/05 Dipeptides
• CPC Class Codes: A61K 38/08 Peptides having 5 to 11 amino acids A61K38/043 - A61K38/046 take precedence
• CPC Class Codes: A61P 25/28 for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• CPC Class Codes: C07K 14/4711 Alzheimer's disease; Amyloid plaque core protein
• CPC Class Codes: C07K 14/575 Hormones derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin C07K14/665, e.g. corticotropin C07K14/695
• CPC Class Codes: C07K 14/585 Calcitonins
• CPC Class Codes: C07K 5/06078 and aromatic or cycloaliphatic
• CPC Class Codes: C07K 5/06165 and Pro-amino acid; Derivatives thereof
• CPC Class Codes: C07K 5/081 the side chain containing O or S as heteroatoms, e.g. Cys, Ser
• CPC Class Codes: C07K 5/0812 and aromatic or cycloaliphatic
• CPC Class Codes: C07K 5/0819 with the first amino acid being acidic
• CPC Class Codes: C07K 5/0823 and Pro-amino acid; Derivatives thereof
• CPC Class Codes: C07K 5/1008 the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
• CPC Class Codes: C07K 5/101 the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
• CPC Class Codes: C07K 5/1016 and aromatic or cycloaliphatic
• CPC Class Codes: C07K 5/1021 with the first amino acid being acidic
• CPC Class Codes: C07K 5/1024 with the first amino acid being heterocyclic
• CPC Class Codes: C07K 7/06 having 5 to 11 amino acids

Abstract

Peptides having at least 2 amino acids and no more than 15 amino acids are provided. The peptides comprise amino acid sequence X-Y or Y-X, wherein X is an aromatic amino acid and Y is any amino acid other than glycine. Also provided are pharmaceutical compositions and kits including such peptides as well as methods using same for diagnosing and treating amyloid associated diseases.

Claims

1. A peptide as set forth in SEQ ID NO:

145.

2. The peptide of claim 1, wherein the peptide is a linear or a cyclic peptide.

3. A pharmaceutical composition comprising as an active ingredient a peptide as set forth in SEQ ID NO:

145 and a pharmaceutically acceptable carrier or diluent.

4. The pharmaceutical composition of claim 3, wherein said peptide is a linear or a cyclic peptide.

5. A method of treating or preventing an amyloid-associated disease in an individual, the method comprising providing to the individual a therapeutically effective amount of a peptide as set forth in SEQ ID NO:

145, thereby treating or preventing an amyloid-associated disease in the individual.

6. The method of claim 5, wherein said peptide is a linear or a cyclic peptide.

7. The method of claim 5, wherein said peptide is an active ingredient of a pharmaceutical composition which also includes a physiologically acceptable carrier.

8. The method of claim 5, wherein said peptide is expressed from a nucleic acid construct.